An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
There’s a lot of talk about GLP drugs lately, and the headline is trying to sort out the different letters — GLP-1, GLP-2 and sometimes people say “GLP-3” — and what they actually do for weight. The short news: GLP-1 drugs are the ones proven to help people lose weight. GLP-2 and the vague “GLP-3” label are different hormones or experimental combos, and they aren’t the same thing as the weight-loss medicines everyone’s hearing about. GLP-1 is a natural hormone made in your gut after you eat. Medicines like semaglutide (the active ingredient in Ozempic and Wegovy) copy that hormone. In plain terms, they tell your brain you’re less hungry, make you feel full faster, and slow how fast your stomach empties. That combination reduces how much people eat, which is why these drugs lead to weight loss for many users. GLP-2 is another gut hormone, but it mostly helps the intestines grow and absorb nutrients — think intestinal maintenance rather than appetite control. It’s used in specific medical settings, like some rare gut diseases, not as a general weight-loss tool. “GLP-3” isn’t a single, well-defined thing; sometimes people use it to mean drugs that hit multiple related receptors at once — for example, molecules designed to activate GLP-1 plus other receptors like GIP or glucagon. Some of those multi-target drugs can produce bigger weight-loss effects in trials, but they’re not magic: the evidence usually comes from controlled clinical studies, and results vary by drug and by how long people took them. Why this matters: if you’re thinking about weight-loss medications, you should know which hormone the drug targets. GLP-1 receptor agonists (the class that includes semaglutide and tirzepatide) are the ones backed by strong human clinical trials showing meaningful weight loss. Other gut hormones or combinations might help or might be useful for other medical problems, but they’re not interchangeable with the well-studied GLP-1 medicines. That distinction affects expectations, cost, side effects, and whether a drug is even approved for weight loss. Caveats and risks: these drugs are prescription medicines with side effects like nausea, diarrhea, constipation, and sometimes more serious issues. Long-term safety and what happens when people stop the drugs are still being studied. Not every new combo or hormone will be approved, and some findings come from early or small studies, not large, long-term human trials. If someone has certain health conditions or is pregnant, these medicines can be risky, so medical guidance is essential. Bottom line: GLP-1 drugs are the proven players in weight loss right now. GLP-2 serves different gut-related roles, and “GLP-3” is a loose term for experimental combos — interesting to watch, but not a substitute for the established GLP-1 treatments.
Source: Forbes